TSBX - Turnstone Biologics Corp. -  [ ]

Ticker Details
Turnstone Biologics Corp.
IPO Date: July 21, 2023
Sector: Healthcare
Industry: Biotech
Market Cap: $8.21M
Activated in VL: False
Average Daily Range
Avg Daily Range: $0.16 | 5.69%
Avg Daily Range (30 D): $0.01 | 1.85%
Avg Daily Range (90 D): $0.01 | 3.91%
Institutional Daily Volume
Avg Daily Volume: .15M
Avg Daily Volume (30 D): .08M
Avg Daily Volume (90 D): .23M
Trade Size
Avg Trade Size (Sh.): 214
Avg Trade Size (Sh.) (30 D): 878
Avg Trade Size (Sh.) (90 D): 465
Institutional Trades
Total Institutional Trades: 7
Avg Institutional Trade: $1.99M
Avg Institutional Trade (30 D): $3.06M
Avg Institutional Trade (90 D): $3.06M
Avg Institutional Trade Volume: .5M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.99M
Avg Closing Trade (30 D): $3.06M
Avg Closing Trade (90 D): $3.06M
Avg Closing Volume: 594.06K
 
News
Jul 5, 2025 @ 1:43 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest...
Source: Halper Sadeh Llc
Jun 30, 2025 @ 10:14 PM
$HAREHOLDER ALERT: Class Action Attorney Juan Mont...
Source: Juan Monteverde
May 13, 2024 @ 9:01 PM
Turnstone Biologics Corp. Reports First Quarter 20...
Source: Turnstone Biologics Corp.
Mar 21, 2024 @ 9:06 PM
Turnstone Biologics Corp. Reports Fourth Quarter a...
Source: Turnstone Biologics Corp.
Feb 21, 2024 @ 11:00 AM
Turnstone Biologics to Participate in Upcoming Inv...
Source: Turnstone Biologics Corp.
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $-2.04 $-.24 $-.51
Diluted EPS $-2.04 $-.24 $-.51
Revenue $M $M $M
Gross Profit
Net Income / Loss $-47.2M $-5.49M $-11.81M
Operating Income / Loss $-44.47M $-5.56M $-9.16M
Cost of Revenue
Net Cash Flow $11.53M $M $M
PE Ratio